Phosducin-like protein (PhLP) is a broadly expressed member of the phosducin (Pd) family of G protein ␤␥ subunit (G␤␥)-binding proteins. Though PhLP has been shown to bind G␤␥ in vitro, little is known about its physiological function. In the present study, the effect of PhLP on angiotensin II (Ang II) signaling was measured in Chinese hamster ovary cells expressing the type 1 Ang II receptor and various amounts of PhLP. Up to 3.6-fold overexpression of PhLP had no effect on Ang II-stimulated inositol trisphosphate (IP 3 ) formation, whereas further increases caused an abrupt decrease in IP 3 production with half-maximal inhibition occurring at 6-fold PhLP overexpression. This threshold level for inhibition corresponds to the cellular concentration of cytosolic chaperonin complex, a recently described binding partner that preferentially binds PhLP over G␤␥. Results of pertussis toxin sensitivity, GTP␥S binding, and immunoprecipitation experiments suggest that PhLP inhibits phospholipase C␤ activation by dual mechanisms: (i) steric blockage of G␤␥ activation of PLC␤ and (ii) interference with G␤␥-dependent cycling of G q ␣ by the receptor. These results suggest that G protein signaling may be regulated through controlling the cellular concentration of free PhLP by inducing its expression or by regulating its binding to the chaperonin.
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Phosducin-like protein (PhLP) is a broadly expressed member of the phosducin (Pd) family of G protein ␤␥ subunit (G␤␥)-binding proteins. Though PhLP has been shown to bind G␤␥ in vitro, little is known about its physiological function. In the present study, the effect of PhLP on angiotensin II (Ang II) signaling was measured in Chinese hamster ovary cells expressing the type 1 Ang II receptor and various amounts of PhLP. Up to 3.6-fold overexpression of PhLP had no effect on Ang II-stimulated inositol trisphosphate (IP 3 ) formation, whereas further increases caused an abrupt decrease in IP 3 production with half-maximal inhibition occurring at 6-fold PhLP overexpression. This threshold level for inhibition corresponds to the cellular concentration of cytosolic chaperonin complex, a recently described binding partner that preferentially binds PhLP over G␤␥. Results of pertussis toxin sensitivity, GTP␥S binding, and immunoprecipitation experiments suggest that PhLP inhibits phospholipase C␤ activation by dual mechanisms: (i) steric blockage of G␤␥ activation of PLC␤ and (ii) interference with G␤␥-dependent cycling of G q ␣ by the receptor. These results suggest that G protein signaling may be regulated through controlling the cellular concentration of free PhLP by inducing its expression or by regulating its binding to the chaperonin.
Eukaryotic cells employ G protein-coupled receptors (GPCRs) 1 to detect a myriad of extracellular signaling molecules and transduce their signals across the plasma membrane. The process is initiated by the binding of the signaling molecule to the extracellular face of the receptor, resulting in a change in receptor conformation. This causes an interaction between the receptor and a heterotrimeric G protein on the intracellular surface of the membrane, catalyzing the exchange of GDP for GTP on the G␣ subunit. In its GTP-bound conformation, G␣ dissociates from G␤␥ and the receptor, allowing both G␣⅐GTP and G␤␥ to interact with effector enzymes or ion channels and thereby regulate their activity. These effectors in turn control second messenger concentrations (cyclic nucleotides, inositol phosphates, lipids, Ca 2ϩ , and K ϩ ) and kinase cascades that dictate intermediary metabolism, cell growth, and differentiation (1) (2) (3) .
Controlling such responses is vital to the cell. Hence, G protein signaling pathways are exquisitely regulated. Regulatory targets are found at each level within the cascade. For example, agonist-bound receptors are rapidly inactivated by phosphorylation, arrestin binding, and internalization (4) . Effector activity is feedback-controlled by second messenger-dependent kinases such as protein kinase C (5), Ca 2ϩ /calmodulindependent protein kinase (6, 7) , and cAMP-dependent protein kinases (8) . The lifetime of many G␣⅐GTP isoforms is decreased by acceleration of GTP hydrolysis by RGS (Regulators of G protein Signaling) proteins and certain effectors such as phospholipase C␤ (9) . G␤␥ activity is also regulated through its interaction with phosducin (Pd) (10 -13) .
Pd is a 28-kDa phosphoprotein found primarily in the retina and pineal gland (10, 14) , although considerably smaller amounts are found in other tissues (15, 16) . Pd sterically inhibits G␤␥ binding activity by associating with the same face of G␤␥ as G␣ and effectors (13, 17, 18) . When complexed to Pd, G␤␥ cannot interact with G␣⅐GDP (13) and participate in receptor-induced nucleotide exchange, nor can it bind effectors and regulate their activity (19, 20) . Phosphorylation of Pd at Ser 73 by cAMP-dependent protein kinase (PKA) changes its interaction with G␤␥ (13, 18, 21, 22) . Though the binding affinity decreases only modestly (13, 23, 24) , part of the G␤␥ binding region of Pd (␣-helix 2) is destabilized, exposing several residues on G␤␥ that contact G␣ (18) . As a result, PKA-phosphorylated Pd does not inhibit G␤␥ from interacting with G␣ (13) , nor does it block G␤␥ activation of effectors (19, 20) . In addition, recent evidence has shown that Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII) phosphorylates Pd at multiple sites, resulting in dramatic inhibition of G␤␥ binding and induction of an interaction with the phosphoserine-binding protein, 14-3-3 (25) . Thus, it appears that the activity of G␤␥ subunits can be regulated by cellular factors that control the phosphorylation state of Pd.
Phosducin-like protein (PhLP), so named for its 41% identity and 65% homology in amino acid sequence to Pcl, was discovered as the product of an ethanol-induced gene in cultured neuronal cells (26) . Like Pd, PhLP binds G␤␥ (27, 28) and inhibits G protein binding to receptors (29) , although unlike Pd, it is not a substrate for PKA (29) . There are other important differences between PhLP and Pd. PhLP has been recently shown to interact in its native state with the cytosolic chaperonin complex (CCT), whereas Pd does not (30) . Moreover, PhLP exhibits a much broader expression pattern than Pd. PhLP mRNA was found in all tissues examined (26, 31) , and immu-noblot analysis has confirmed PhLP protein expression in diverse tissues and cell lines. 2 Thus, PhLP could be a ubiquitous regulator of G protein signaling pathways, although it could also fulfill other physiological functions.
In this report, we examine the ability of PhLP to regulate a G protein pathway by measuring its effects on angiotensin II (Ang II) signaling. Ang II is a peptide hormone that regulates numerous cardiovascular parameters including blood volume, blood pressure, and vascular tone (32) . Ang II controls vascular tone by inducing vascular smooth muscle cell (VSMC) contraction (33) as well as by stimulating VSMC hypertrophy (34) and hyperplasia (35) . Two known GPCRs, designated AT 1 R and AT 2 R, mediate the physiological effects of Ang II. Most of these effects are elicited by AT 1 R, which couples to G q (36 -39) , G 12 (39), G 13 (40) , G i (41) (42) (43) , and G o (43) in various cellular contexts. These G proteins activate PLC␤ through G q ␣ or the G␤␥ derived from G 12/13 or G i/o (44) (49) . CHO/AT 1 R cells were grown and passaged at 37°C under 5% CO 2 in Dulbecco's modified Eagle medium (DMEM, Invitrogen) containing 10% fetal bovine serum (Invitrogen), 100 units/ml penicillin/streptomycin (Invitrogen) and 1 g/liter G418 sulfate (Mediatech, Herndon, VA). Rat PhLP was subcloned from a previous construct in the pCR3.1 vector (Invitrogen, Carlsbad, CA) (29) into the pZeoSV(ϩ) vector (Invitrogen) at the BamHI and EcoRV sites. Rat Pd was amplified from a previous construct in the pET15b vector (Novagen, Madison, WI) (17) by PCR with the forward primer 5Ј-ATG GAA GAA GCC GCA AGC CAA AGC TTA GAG and the reverse primer 5Ј-TTA CTC GAT ATC TTC ATC TTC CGT GTT GTT CTG CCC and then directly ligated into the pCR3.1 linearized vector from the TA cloning kit (Invitrogen). The rat Pd S73A variant was created in pCR3.1 by site-directed mutagenesis using the QuikChange protocol (Stratagene, La Jolla, CA). Both Pd constructs were then subcloned from pCR3.1 into pZeoSV(ϩ) at the BamHI and EcoRV sites. The integrity of each construct was confirmed by sequence analysis. CHO/AT 1 R cell lines expressing PhLP, Pd, and Pd S73A were prepared by transfection with these pZeoSV(ϩ) plasmids using LipofectAMINE reagent (Invitrogen) according to the manufacturer's protocol with 3 g of DNA and 10 l of LipofectAMINE per 35-mm well. Cells were selected for Zeocin resistance in the above media containing 0.5 g/liter Zeocin (Invitrogen). Clonal cell lines expressing various amounts of PhLP, Pd, and PdS73A were identified by immunoblot analyses using antibodies specific to PhLP and Pd (29) .
IP 3 Determinations-CHO/AT 1 R cells were split equally into 6-well plates and were allowed to recover for a minimum of 24 h at which point they were ϳ80% confluent. The cells were serum-starved by washing three times for 5 min with 1 ml of serum-free Dulbecco's modified Eagle's medium and incubating in 2 ml of serum-free medium for 48 -72 h. At this time the cells were nearly confluent. Cells were then stimulated with 1 ml of fresh serum-free medium containing 10 Ϫ6 M Ang II. At the times indicated, cellular reactions were quenched, and membranes were permeabilized with 200 l of 100% trichloroacetic acid. Cells were harvested by scraping, and the suspension was centrifuged at 14,000 ϫ g for 10 min at 4°C. IP 3 in the resulting supernatant was extracted and quantified using a [ 3 H]inositol 1,4,5-trisphosphate radioreceptor assay kit as described by the manufacturer (PerkinElmer Life Sciences). Protein concentrations were determined in parallel wells by harvesting cells in 200 l of 1% SDS and measuring the protein concentration using the BCA protein assay reagent (Pierce). For PTX experiments, cells were pretreated overnight with 100 ng/ml PTX (Calbiochem, San Diego, CA) in 1.0 ml of serum-free medium prior to Ang II stimulation. Cells were stimulated with 10 Ϫ8 to 10 Ϫ6 M Ang II as indicated.
Immunoblotting and Quantification of PhLP, Pd, and G proteins in CHO/AT 1 R Cells-PhLP-expressing CHO/AT 1 R cell lines were cultured in 6 ϫ 35 mm-well plates to near confluence. Cells were washed twice with phosphate buffered saline (PBS) and harvested in 200 l of 1% SDS. Protein concentrations were determined using the BCA protein assay reagent. Laemmli SDS-PAGE sample buffer was added, and 10 g of total protein were loaded onto a 12% SDS gel along with increasing amounts of purified PhLP, Pd (24) , or G␤ 1 ␥ 1 (13) on the same gel and subjected to electrophoresis. Samples were transferred to nitrocellulose, blocked, and then incubated with either an antibody specific to PhLP or Pd (29) or an antibody prepared against the C-terminal 11 residues common to G␤ [1] [2] [3] [4] (G␤SW, Ref. 50) . After secondary antibody incubation with a peroxidase-conjugated goat anti-rabbit IgG, the blots were developed using ECLϩ (Amersham Biosciences) according to the manufacturer's protocol, and bands were quantified using a Storm 860D phosphorimager in chemifluorescence mode (Molecular Dynamics, Sunnyvale, CA). Curves were generated from each data set, and the amounts of PhLP or G␤ were determined by comparison with the standards. Cellular concentrations of PhLP were calculated using values of 250 pg of protein and 1500 m 3 volume per CHO cell (51) . The expression of various G␣ subunits in CHO/AT 1 R cells was determined in a similar manner. Membranes from CHO/AT 1 R cells were prepared as previously described (52) , and their protein concentration was determined using the BCA assay. 1.9 g of membrane protein along with 15 and 30 ng of purified G q ␣, G 12 ␣, or G 13 ␣ (a gift from Dr. T. Kozasa, Department of Pharmacology, University of Illinois at Chicago) were separated by SDS-PAGE on 12% gels and subjected to immunoblot analysis using 1:500 dilutions of antisera specific to G␣ q/11 , G␣ 12 , and G␣ 13 (Santa Cruz Biotechnology). Blots were developed as above, and the amounts of G␣ were estimated by comparison with the standards.
AT 1 R Expression Level Determinations-CHO/AT 1 R cells expressing Pd, PdS73A, or PhLP were grown in four 100-mm dishes to ϳ80% confluence and were serum-starved as described for IP 3 (53) . The data were fit to a simple one-to-one binding equation using the Kaleidagraph graphics program (Synergy Software, Reading PA), and the total number of binding sites per microgram of protein was obtained from the saturation point of the curve fit.
GTP␥S Binding Measurements-To measure the coupling of AT 1 R to specific G␣ subunits, GTP␥S co-immunoprecipitation experiments were performed following a modification of a previously described method (54) . Briefly, membranes from a 100,000 ϫ g centrifugation of a CHO/ AT 1 R cell extract were prepared as previously described (52), and their protein was determined by the BCA assay. Membranes were diluted to a final concentration of 0.125 mg/ml in the presence of 200 pM [ 35 
S]GTP␥S (PerkinElmer Life Sciences). Activation was initiated by addition of Ang II to a final concentration of 10
Ϫ8 or 10 Ϫ6 M. Reactions were incubated for 1 h at 37°C, after which Igepal CA360 detergent (Sigma) was added to a final concentration of 0.27%, and the incubation was continued an additional 30 min. 1 l of G␣ q/11 or G␣ 12 (Santa Cruz Biotechnology) antiserum was added and incubated for 1 h at 4°C. 20 l of a 50% slurry of protein A/G-agarose (Santa Cruz Biotechnology) was added, and samples were incubated an additional 90 min. The beads were washed three times, brought up in 5 ml of scintillation mixture, and [
35 S]GTP␥S in the immunoprecipitate was quantified using a Tri-Carb 2100TR liquid scintillation counter (Packard, Meriden, CT).
To measure total activation of G␣ subunits by AT 1 R, GTP␥S membrane binding experiments were performed. Cells were serum-starved as described for IP 3 determinations, washed with PBS, and harvested by scraping cells from the wells in ice-cold 20 mM HEPES pH 7.4, 5 mM CaCl 2 . Cells were incubated 15 min on ice in this buffer to allow hypotonic lysis to occur and were further disrupted by repeated trituration through a 23-gauge needle. Cell membranes were harvested by centrifugation at 20,000 ϫ g at 4°C for 30 min and were resuspended in Assay Buffer (20 mM HEPES pH 7.4, 100 mM NaCl, 5 mM MgCl 2 ). Total membrane protein concentration was determined using the BCA assay. for varying times and then rapidly filtered through GF/B filter paper (prewashed with assay buffer containing 0.5% w/v bovine serum albumin) using the Brandel cell harvester. The filters were then washed three times with Assay Buffer, and the protein-bound radioactivity was determined by liquid scintillation counting of the filters. The Ang IIinduced component of GTP␥S binding was determined by subtraction of the GTP␥S bound in the absence of Ang II from that bound in the presence of Ang II and was between 40 and 50% of the total binding. The number of moles of GTP␥S bound was calculated from the Ang II-induced cpm-bound by correcting for the efficiency of scintillation counting of [ 35 S]GTP␥S on the filters and converting the resulting dpm-bound to moles-bound using the specific activity of the
The total G␤␥ in these membrane preparations was determined as described above for whole cell extracts. Samples containing 0.4 -1.6 g of total membrane protein or 40 -160 fmol of purified G␤ 1 ␥ 1 were analyzed by SDS-PAGE and immunoblotting. The resulting ECL bands were quantified, and the amount of G␤ in the membrane preparation was determined by comparing the ECL signal with those of the G␤ 1 ␥ 1 standards.
Co-immunoprecipitation of PhLP and G␤␥-CHO/AT 1 R cell lines were cultured in 35-mm plates to near confluence. 1 g of PhLP or LacZ fused to a 3Ј c-Myc-His 6 tag in the pcDNA3.1 vector was transiently transfected into cells using the LipofectAMINE reagent according the manufacturer's protocol. Cells were allowed to recover for 48 h after which they were rinsed twice with PBS and harvested in 200 l of PBS containing 2% Igepal detergent (Sigma), 600 M phenylmethylsulfonyl fluoride, and 8 M E64 (Roche Molecular Biochemicals). Cell lysates were triturated with a 25-gauge needle and centrifuged at 7,000 ϫ g for 15 min at 4°C. 5 l of affinity-purified anti-c-Myc antibody (BioMol, 0.7 mg/ml) was added and incubated for 30 min at 4°C. 20 l of a 50% protein A/G-agarose slurry (Promega, Madison, WI) was then added and incubated for 1 h at 4°C. Samples were centrifuged at 3,000 ϫ g for 1 min, and the beads were washed three times with PBS containing 2% Igepal CA-360. Beads were brought up in 20 l of 2ϫ Laemmli SDS-PAGE sample buffer and heated at 90°C for 5 min. 7 l of each sample were separated by SDS-PAGE on 12% gels and subjected to immunoblot analysis. Dilutions of primary antibodies were as follows: anti-PhLP (29), 1:50,000; anti-G␤ 1 , 1:10,000 (antiserum to residues 1-14, Ref. 55); and anti-G␣ q/11 , 1:500 (antiserum W082, Ref. 56).
RESULTS
Stable Expression of PhLP, Pd, and PdS73A in CHO/AT 1 R Cells-In order to assess the effect of PhLP on Ang II signaling, CHO/AT 1 R cells were stably transfected with a PhLP, Pd, or PdS73A cDNA expression construct. Colonies were screened by immunoblot analysis to determine respective protein expression levels. One low and one high expressing cell line of each construct were chosen for comparison and were used in subsequent experiments. Before transfection with PhLP cDNA, CHO/AT 1 R cells expressed amounts of PhLP that were easily detectable by immunoblotting. After transfection and selection, the low expressing cell line had 2 fmol of PhLP/g of total protein whereas the high expressing cell line had 5 fmol/g, compared with non-transfected cells, which had 0.7 fmol/g (Fig. 1A) . In contrast, Pd was not detected in non-transfected CHO/AT 1 R cells or in one cell line that had undergone transfection with Pd cDNA and subsequent selection. However, another cell line had 3.0 fmol of Pd/g of protein. For PdS73A, the low expressing cells contained 0.15 fmol of PdS73A/g of protein whereas the high expressing cells had 1.2 fmol/g.
Effect of PhLP, Pd, and PdS73A Overexpression on Ang IIinduced IP 3 Production-Ang II induced substantial and rapid increases in IP 3 concentration in CHO/AT 1 R cells (Fig. 1, B-D) . These responses are very similar to those of VSMC (39) . Both reach peak IP 3 concentrations at ϳ15 s and then decay slowly. After about 90 s, the IP 3 concentration has decreased to 50% of its maximal value. The initial increase is believed to stem from the activation of PLC␤ by G q ␣⅐GTP or G␤␥, resulting in an increase in cytosolic Ca 2ϩ concentration. Increased Ca 2ϩ activates Ca 2ϩ -dependent tyrosine kinases that initiate a series of tyrosine phosphorylation events, which result in PLC␥ activation (39) . This PLC␥ activity is believed to be responsible for the sustained increase in IP 3 at later time points (39) . Overexpression of PhLP decreased IP 3 production by 60 -70% in both the initial and sustained portions of the response (Fig. 1B) . This effect over the entire IP 3 response period suggests that PhLP is blocking PLC␤ activity, and as a result PLC␥ activity is also inhibited.
In contrast, overexpression of Pd had very little effect on IP 3 production (Fig. 1C) , despite the fact that the Pd level was nearly as high as the PhLP high expressor. The contrasting effects of PhLP and Pd could result from inactivation of Pd as a result of phosphorylation by PKA, CaMKII, or other kinases endogenous to these cells. To test this possibility, a variant of Pd (PdS73A) was also transfected into CHO/AT 1 R cells. This variant no longer has a major PKA and CaMKII phosphorylation site at Ser 73 , making it insensitive to inactivation by PKA (16, 18) and significantly less sensitive to inactivation by CaMKII (25) . The response of PdS73A cells to Ang II was similar to cells transfected with PhLP. Overexpression also caused a 60 -70% decrease in IP 3 production throughout the time-course of the response (Fig. 1D ). This level of inhibition was achieved with ϳ4-fold less PdS73A than PhLP. Thus, Pd appears to be a better inhibitor of Ang II-induced IP 3 production than PhLP when Ser 73 is not phosphorylated, although when Ser 73 is phosphorylated, Pd is inactivated. 3 Production-PhLP is the only member of this gene family normally expressed in CHO cells and most other cell types, therefore attention was focused on the details of PhLP inhibition of Ang II signaling in these cells. It is possible that the observed differences in IP 3 responses to Ang II were caused by clonal variation in the CHO/AT 1 R cell lines. Therefore, two other cell lines expressing intermediate amounts of PhLP were examined along with the parent CHO/AT 1 R cell line. Fig. 2A shows the immunoblot quantification of the amounts of PhLP in these cells. Cell lines are identified A-D with A expressing the most PhLP and D expressing the least amount of PhLP, ranging from 6.9-to 2.7-fold greater than the parent cells, respectively. Those cell lines with the highest level of PhLP expression produced the least IP 3 in response to Ang II (Fig. 2B) . A plot of the IP 3 response versus the cellular concentration of PhLP revealed an interesting correlation (Fig. 2C) . IP 3 production was unaffected by PhLP concentrations up to ϳ0.5 M, but the responses decreased precipitously at higher concentrations. Fitting the data to a cooperative inhibition equation yielded an apparent cooperativity coefficient (n) of 6.8, indicating a high degree of sensitivity of the Ang II-induced IP 3 response to PhLP concentration once the threshold level had been reached.
Effect of Increasing Cellular Concentrations of PhLP on Ang II-induced IP
AT 1 R Expression Levels-To begin to address the mechanism of PhLP inhibition of Ang II signaling, the effects of PhLP overexpression on receptor number were examined. It is unlikely that PhLP and PdS73A inhibition could be a result of random differences in AT 1 R levels in all of these cell lines. However, it is possible that PhLP could influence AT 1 R levels in some manner. A radiolabeled Ang II binding assay was used to determine the amount of AT 1 R in membrane preparations from each cell line. There was no consistent correlation between Ang II-induced IP 3 production and AT 1 R expression (Table I) . Receptor numbers varied between 7 and 23 fmol/g of membrane protein, but cell lines with the highest receptor number did not have the greatest IP 3 responses and vice versa. Moreover, PhLP or Pd expression level had no influence on receptor number. Normally, one would expect that increases in receptor number would result in increased Ang II-induced IP 3 production. However, these cell lines express high levels of receptor that appear to be in excess of that necessary for a saturating IP 3 response. This follows from the fact that receptors act catalytically, activating many G proteins per activated receptor. Consequently, once a certain density of receptors in the membrane is reached, further increases in receptor number do not increase the rate of G protein activation. This conclusion is supported by GTP␥S binding data which showed no difference in the initial rate of Ang II-induced GTP␥S binding in PhLP cell lines A and D (see Fig. 4A ) despite their 1.4-fold difference in receptor number. Thus, it appears that the observed differences in Ang II-induced IP 3 production do not result from an indirect effect of PhLP on AT 1 R expression.
PhLP Inhibition before or after G Protein Activation by AT 1 R-The most likely target of PhLP inhibition of Ang II signaling is G␤␥. The mechanism of this inhibition could be either to disrupt the inactive G protein heterotrimer before activation by the AT 1 R or to sequester the free G␤␥ that is liberated from the heterotrimer after activation. In the former, PhLP would displace G␣ from G␤␥ before receptor-catalyzed GTP exchange caused the heterotrimer to dissociate, thereby decreasing the pool of heterotrimers available for activation. In the latter, PhLP would bind the free G␤␥ that dissociates from G␣ upon activation and block its ability to directly activate PLC␤, or its ability to reassociate with G␣⅐GDP after hydrolysis of GTP by G␣. One way to assess the viability of these potential mechanisms is to measure the stoichiometry of PhLP and G␤␥ expression. PhLP most likely binds G␤␥ in a one-to-one com- plex in a manner similar to that of Pd (13, 17) . This means that if PhLP is disrupting heterotrimers before activation, it must be expressed at least at a level comparable to the total G␤␥ in the cell. Alternatively, if PhLP inhibits free G␤␥, it must be expressed only in amounts similar to the G␤␥ liberated after G protein activation. n ), where IC 50 is the half-maximal inhibition, and n is the apparent cooperativity coefficient. The curve fit yielded an IC 50 value of 0.8 M and an n value of 6.8.
The level of G␤ expression was measured by quantitative immunoblot analysis (Fig. 3) . In all the PhLP cell lines, there was significantly less PhLP than total G␤ (see Fig. 3, inset) . Cell lines A-C had similar ratios of PhLP to G␤, in the 0.15-0.20 range. Cell line D and the CHO-AT 1 R cells had lower ratios, between 0.05 and 0.10. These numbers show that there is not enough PhLP to disrupt G protein heterotrimers before activation. Further support of this conclusion comes from GTP␥S binding experiments (Fig. 4A) . Receptor-catalyzed binding of GTP␥S locks G␣ in its active state because it cannot hydrolyze GTP␥S to GDP. As a result, G␣⅐GTP␥S cannot reassociate with G␤␥ and be reactivated by the receptor. Hence in the presence of GTP␥S, G protein cycling is blocked, and the amount of Ang II-induced GTP␥S-bound results from a single round of G protein activation by AT 1 R. If overexpression of PhLP causes disruption of the G protein heterotrimer prior to activation, then GTP␥S binding would be reduced in cell lines with more PhLP. Membrane fractions were isolated from cell lines A and D, and the amount of Ang II-induced GTP␥S binding was measured (Fig. 4A) . The rate of Ang II-induced
FIG. 3. Quantification of G␤ expression. The amount of G␤ in
PhLP-expressing cells lines was determined by quantitative immunoblotting as described in the legend to Fig. 2 using an anti-G␤ antibody that recognizes G␤ [1] [2] [3] [4] (50) . The four lanes on the left contain increasing amounts of purified G␤ 1 ␥ 1 , and the five lanes on the right contain 10 g of total cell extract. The bar graph shows the G␤ quantification from 3-5 separate experiments, and the inset gives the resulting PhLP to G␤ ratio for each cell line. GTP␥S binding was the same in both cell lines, indicating that before Ang II activation, the pool of G protein heterotrimers capable of interacting with AT 1 R was unaffected by the level of PhLP expression. Together the observed excess of total G␤␥ over PhLP and the lack of effect of PhLP on GTP␥S binding rule out the possibility that PhLP causes G␤␥ to dissociate from G␣ prior to activation. Consequently, PhLP must be acting on the free G␤␥.
These data indicate that it is the stoichiometry of PhLP to free G␤␥ and not to total G␤␥ that determines whether PhLP can inhibit signaling. Therefore, the amount of free G␤␥ in these cells was determined using the GTP␥S experiment. By extrapolating the time course of GTP␥S binding to infinite time (Fig. 4A) , the amount of Ang II-activated G␣ can be determined, given that one GTP␥S binds per G␣ subunit. The average value of activated G␣ from three experiments was 1.0 Ϯ 0.3 fmol/g of membrane protein. This value is also equal to the number of G␤␥ activated since equal amounts of G␣⅐GTP␥S and G␤␥ are activated per heterotrimer. To determine the percentage of G␤␥ activated by Ang II, the total G␤␥ in the membrane preparation was measured by quantitative immunoblotting (Fig. 4B) , yielding 64.1 Ϯ 19.5 fmol of G␤/g of membrane protein. Thus, 1.6 Ϯ 0.7% (n ϭ 3) of the total G␤␥ was activated by Ang II. In all of the cell lines, PhLP expression exceeded this amount of free G␤␥, ranging from a 3-fold excess in the CHO/AT 1 R cells to a 10-fold excess in cell line A.
From these results, inhibition of Ang II-induced IP 3 production would be expected in all the cell lines, not just those with cellular concentrations of PhLP above the 0.5 M threshold observed in Fig. 2C . An explanation of this apparent inconsistency comes from a consideration of the concentration of free PhLP in the cell. It has been recently demonstrated that PhLP binds the cytosolic chaperonin complex with higher affinity than it does G␤␥ (30) . The concentration of the chaperonin is 3.5-fold higher than endogenous PhLP in CHO cells (30) . This corresponds to 0.46 M of the chaperonin complex that could bind and sequester PhLP from G␤␥. This concentration is very close to the observed threshold for PhLP inhibition of IP 3 production (Fig. 2C) , suggesting that PhLP does not bind G␤␥ until its expression exceeds that of the chaperonin complex. Above this level, there is free PhLP available to inhibit G␤␥ signaling. To bind G␤␥, the free concentration of PhLP in the cell must be in the range of the 0.1 M K d reported for the PhLP-G␤␥ interaction (24) . An estimate of the free PhLP can be obtained by subtracting the concentration potentially bound to the chaperonin from the total cellular PhLP. Using this estimate, an IC 50 of ϳ0.3 M can be obtained for free PhLP inhibition of IP 3 production, which is in reasonable agreement with the measured K d . In addition, these observations are consistent with PdS73A inhibition of IP 3 production at much lower concentration than PhLP (Fig. 1) , given that Pd does not bind the chaperonin (30) .
PhLP Inhibition of Direct G␤␥ Activation of PLC␤ or of G q ␣ Cycling-G proteins activate PLC␤ through the G␣ subunit of G q family members and through G␤␥ subunits (44) . Previous work with Pd showed that it inhibited G␤␥-mediated activation of PLC␤ by receptors coupled to G i , but had no effect on G q ␣-mediated PLC␤ activation by receptors coupled to G q in COS-7 cells (19) . It was therefore important to determine whether PhLP was inhibiting a G␤␥ or G q ␣-dependent pathway in these CHO/AT 1 units can be blocked by pertussis toxin (PTX)-catalyzed ADPribosylation of G i/o ␣ at a C-terminal cysteine (57, 58) . Other G␣ families, including G q ␣, lack this cysteine and are unaffected by PTX (59) . The effects of PTX were tested in cell lines A and D at several different Ang II concentrations (Fig. 5) . At 10 Ϫ8 M Ang II (Fig. 5A) , IP 3 production was insensitive to PTX, yet the response was inhibited 40% by PhLP overexpression. At 10 Ϫ7 M Ang II (Fig. 5B) , IP 3 production was inhibited 20% by PTX, and PhLP inhibition increased to 55%. At 10 Ϫ6 M Ang II (Fig. 5C ), IP 3 production was inhibited 45% by PTX, and PhLP inhibition increased to 60%. Thus, as the Ang II concentration increased so did the sensitivity to PTX, indicating that activation of PLC␤ by the G␤␥ produced from G i/o increased as Ang II increased. The corresponding increase in PhLP inhibition indicates that it was blocking G␤␥ activation of PLC␤, consistent with what was observed with Pd (19) . PhLP inhibition of G␤␥ derived from G i/o was nearly complete as evidenced by the minor effect of PTX in high expressing cells.
At all concentrations of Ang II, the PTX-insensitive portion of IP 3 production was decreased 40 -50% by PhLP overexpression (compare ϩPTX in cell lines A and D). This result was somewhat unexpected considering the inability of Pd to block PTX-insensitive activation of PLC␤ (19) , but the data can be understood by examining the mechanisms of Ang II-mediated activation of PLC␤. There are two possible ways in which the AT 1 R can activate PLC␤ in a PTX-insensitive manner, either through G q ␣ or the G␤␥ derived from G 12 or G 13 . PhLP must be inhibiting one or both of these pathways. In order to determine which pathway is functioning in this system, CHO/AT 1 R cells were first examined for expression of various G␣ subunits. Immunoblot analyses using antibodies specific to G q/11 ␣, G 12 ␣, or G 13 ␣ showed high levels of G 12 (ϳ1000 fmol/g of membrane protein), 3 moderate levels of G q (ϳ50 fmol/g of membrane protein) and almost undetectible G 13 (Ͻ10 fmol/g of membrane protein) in CHO/AT 1 R membranes (Fig. 6A) . Thus, significant activation of PLC␤ by G␤␥ derived from G 13 could be ruled out. Further investigation was pursued to determine if AT 1 R was coupling to G q or G 12 using a G protein activation assay. In this assay, an Ang II-induced increase in the co-immunoprecipitation of [
35 S]GTP␥S with antibodies to specific G␣ subunits indicates AT 1 R activation of that subunit. At 10 Ϫ8 M Ang II, there was a 1.5-fold increase in GTP␥S binding to G q over non-stimulated levels, whereas there was no Ang II-induced increase in GTP␥S binding to G 12 (Fig.  6B) . At 10 Ϫ6 M Ang II, there was a similar 1.4-fold increase for G q , whereas G 12 showed a substantial 2.4-fold increase over basal levels. These results indicate that AT 1 R couples to G q at 10 Ϫ8 M Ang II and that coupling is essentially saturated with respect to Ang II at that concentration. In contrast, AT 1 R does not couple to G 12 at 10 Ϫ8 M Ang II, but it does couple efficiently at 10 Ϫ6 M Ang II. Thus, the inhibition by PhLP observed at 10
Ϫ8
M Ang II must be occurring through disruption of G q ␣ activation of PLC␤ and not through obstruction of G␤␥ activation (see "Discussion").
Co-immunoprecipiation of G␤␥ but Not G␣ with PhLP-The data presented thus far do not rule out the possibility that PhLP could inhibit signaling by directly binding G␣, as has been suggested for Pd in one report (60) . To address this possibility, a series of immunoprecipitation experiments were performed. A cDNA construct encoding PhLP with a C-terminal c-Myc epitope tag was prepared and transiently expressed in CHO/AT 1 R cells. The fusion protein was immunoprecipitated 3 The ϳ1000 fmol of G␣/g of membrane protein reported in Fig. 6A is greater than the 64 fmol of G␤␥/g of membrane protein reported in Fig. 4B . The difference results from enrichment of G proteins in the 100,000 ϫ g membrane fraction used in Fig. 6A compared to the 20,000 ϫ g membrane fraction used in Fig. 4 and Table I . with an anti-c-Myc antibody, and the precipitates were immunoblotted using antibodies specific to PhLP (29) , G␤ 1 (55), or G q ␣ family members (56) . Fig. 7 shows that G␤␥ co-immunoprecipitated with PhLP whereas G q ␣ did not, suggesting a lack of high affinity interactions between PhLP and G q ␣ in these cells. These results suggest that the inhibitory effect of PhLP on signaling at 10 Ϫ8 M Ang II is mediated through its binding to G␤␥ and not G q ␣.
The data presented strongly suggest that PhLP binds free G␤␥ after Ang II activation. A prediction from this observation is that Ang II would increase in the amount of G␤␥ co-immunoprecipitating with PhLP. However, this was not observed. Similar amounts of G␤␥ were found in immunoprecipitates of PhLP with or without Ang II (data not shown). The reason for this apparent discrepancy could be the detergent used to dissolve the cell membrane in the immunoprecipitation protocol. Part of the PhLP binding site on G␤␥ overlaps the membrane association site of G␤␥ (17) . Hence PhLP would have greater access to G␤␥ if the heterotrimer were not associated with the membrane. This would result in G␤␥ co-immunoprecipitation in the absence of Ang II, which would not be expected to increase measurably in the presence of Ang II because of the small percentage of G␤␥ released upon activation (see Fig. 4B ). (19) . The inhibition is believed to occur through competition between PLC␤ and Pd for the same binding surface on G␤␥ (17, 61) . Analogously, PhLP inhibition of G␤␥ activation of PLC␤ at high Ang II concentration (10 Ϫ6 M) most likely occurs through steric hindrance of the interaction of PLC␤ with G␤␥ (Fig. 8) .
The mechanism of PhLP inhibition of PLC␤ activation observed at 10 Ϫ8 M Ang II concentration is more complex. AT 1 R effectively couples to G q under these conditions and activates PLC␤ through G q ␣⅐GTP (36 -39, 44) . Activation of PLC␤ by G q ␣⅐GTP has been extensively studied and can be described in terms of a kinetically trapped signaling complex of ligandbound receptor, G q and PLC␤ residing on a lipid bilayer (9, 62, 63) . PLC␤ is activated in this complex by multiple rounds of nucleotide exchange and GTP hydrolysis. PhLP may bind G␤␥ in this complex, compete with G q ␣ for G␤␥ binding, and thereby slow nucleotide exchange (Fig. 8) . A decrease in nucleotide exchange on G q ␣ would decrease the time that PLC␤ is active, thereby decreasing the rate of IP 3 production. This mechanism is analogous to that proposed for Pd in photoreceptor cells, in which Pd binding to G␤␥ blocks cycling of G t ␣ and inhibits phosphodiesterase activation by G t ␣ (12, 13).
An alternative mechanism for PhLP inhibition of PLC␤ activation at 10 Ϫ8 M Ang II is that PhLP blocks activation by the G␤␥ derived from G q . This possibility appears unlikely because the PLC␤1 isoform found in CHO cells (64) is inefficiently activated by G␤␥ compared with G q ␣. In solution, half-maximal activation by G␤␥ is ϳ25 nM (65, 66) compared with ϳ 1 nM for G q ␣ (65), whereas the magnitude of the activation is similar. Activation of G q would produce equal amounts of G␣ and G␤␥ subunits, and thus G q ␣ activation of PLC␤ would be expected to predominant. Thus, the most likely mechanism of PhLP inhibition of G q -mediated activation of PLC␤1 is by impeding the cycling of G q ␣ and not by obstructing free G␤␥ activation of PLC␤1.
These proposed mechanisms are consistent with the observation that inhibition of IP 3 production occurred when PhLP levels were 5-7-fold less than the total G␤␥, but 10-fold greater than the activated G␤␥. This free G␤␥ would be distributed between that derived from G i/o and G 12 or that required for G q ␣ cycling. There would be sufficient PhLP to inhibit the G␤␥ needed for both direct activation of PLC␤ and G q ␣ cycling. In contrast, there is insufficient PhLP compared with total G␤␥ to support an alternative mechanism in which PhLP disrupts G protein heterotrimers prior to activation. Consistent with this observation, the GTP␥S data (Fig. 4A) indicate that PhLP has little effect on the G protein heterotrimer bound to the membrane prior to activation.
Differences between PhLP and Pd or GRK2ct in Inhibiting G␣ Cycling-The C-terminal G␤␥ binding domain of G protein receptor kinase 2 (GRK2ct) has been used as a specific inhibitor of G␤␥ function (67) and has been employed to assess the role of G␤␥ in G protein-mediated activation of PLC␤. Overexpression of GRK2ct inhibited G␤␥-mediated activation of PLC␤ through the ␣ 2 -adrenergic and M2 muscarinic receptors but not G q ␣-mediated activation through the ␣ 1 -adrenergic and M1 muscarinic receptors (67) . Pd also inhibited G␤␥ but not G q ␣-mediated activation of PLC␤ through these same receptors (19) . In contrast, PhLP appears to inhibit both G q ␣ and G␤␥-mediated activation of PLC␤. The observed differences between GRK2ct and PhLP may result from structural differences in the way these polypeptides bind G␤␥ and sterically block access On the left, the cycling of G q is depicted. Ang II-bound AT 1 R interacts with the G q ⅐GDP heterotrimer causing GTP exchange. G q ␣⅐GTP interacts with PLC␤ activating phosphatidylinositol 4,5-bisphosphate hydrolysis. Concomitantly, PLC␤ accelerates GTP hydrolysis on G q ␣, returning the system to its ground state. It has been proposed that cycling through this activation loop maintains the receptor, G q ␣, G␤␥, and PLC␤ in a kinetically trapped signaling complex (9) . PhLP may inhibit PLC␤ activation by interacting with G␤␥ and slowing or disrupting the cycle. On the right, PhLP blocks direct activation of PLC␤ by the G␤␥ derived from G 12 or G i . The amount of PhLP available to bind G␤␥ is dependent on its binding to CCT (30) .
to different regions of its surface, or they may result from differences in binding affinity. GRK2ct binds G␤␥ with a K d of ϳ3 M (68) while PhLP binds G␤␥ with a K d of 100 nM (24) . It is possible that only PhLP binds with sufficiently high affinity to block the cycling of G q ␣. With regard to Pd and PhLP, the observed differences appear to stem from differences in phosphorylation state (see Fig. 1 ). Thus, the apparent discrimination of Pd between G q ␣-and G␤␥-mediated total IP production reported previously (19) may have resulted more from the effect of the signal on the phosphorylation state of Pd than on an inability of unphosphorylated Pd to inhibit G q cycling. During the 45-min total IP measurement period used in those studies, signaling through G i would be expected to decrease Pd phosphorylation via PKA (21), while signaling through G q would be expected to increase Pd phosphorylation via CaMKII (25) . Since PhLP lacks the Pd phosphorylation sites, its activity is not affected by the signal, and as a result, PhLP inhibits both G q ␣-and G␤␥-mediated IP 3 production. By analogy, unphosphorylated Pd would be expected to inhibit both pathways as is suggested by the PdS73A results (Fig. 1D) .
Ang II Concentration Dependence of AT 1 R Coupling to Different G Proteins-An interesting observation from these studies is that AT 1 R couples to different G␣ subunits depending on the concentration of Ang II. At 10 Ϫ8 M Ang II, AT 1 R coupled only to G q ␣, whereas at 10 Ϫ6 M Ang II, AT 1 R also coupled to G i/o and G 12 . This observation indicates that Ang II-bound AT 1 R forms a high affinity complex with G q , whereas it forms much lower affinity complexes with G i/o or G 12 , indicating conformational differences in AT 1 R when bound to G q compared with G i/o or G 12 . Such agonist concentration-dependent differences in coupling have been observed for other GPCRs (69 -71) .
Physiological Implications-In addition to G␤␥, PhLP also binds the cytosolic chaperonin complex, CCT (30) . Coimmunoprecipitation data indicate that PhLP binds CCT with higher affinity than G␤␥. This is consistent with the observation that PhLP did not inhibit Ang II signaling until its concentration exceeded that of CCT in the cell (Fig. 2C) . If PhLP acts as a physiological inhibitor of G␤␥ signaling, then under some conditions, its concentration must exceed that of CCT. Alternatively, PhLP binding to CCT could be regulated so that in response to appropriate signals, PhLP could be released from CCT to bind G␤␥ and inhibit its function. The results described here provide the impetus to further investigate the potential mechanisms of regulation of G protein signaling by PhLP.
